Results 191 to 200 of about 10,819,007 (349)

Capabilities and Equality of Health II: Capabilities as Options [PDF]

The concept of capabilities, introduced originally by Sen, has inspired many researchers but has not found any simple formal representation which might be instrumental in the construction of a comprehensive theory of equality.
Hans Keiding
core  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Estimation of Health Utility Values for Eosinophilic Granulomatosis With Polyangiitis. [PDF]

Pharmacoecon Open
Buguth B, Bernarde J, Aggio D, Pimprikar A, Watt M, Westerink L, Persson J, Lloyd A.   +7 more
europepmc   +1 more source

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia. [PDF]

Pharmacoecon Open, 2023
Kruger E, Aggio D, de Freitas H, Lloyd A.   +3 more
europepmc   +1 more source

Approaches to Estimating the Health State Dependence of the Utility Function [PDF]

If the marginal utility of consumption depends on health status, this will affect the economic analysis of a number of central problems in public finance, including the optimal structure of health insurance and optimal life cycle savings.
Finkelstein, Amy N., Luttmer, Erzo F. P., Notowidigdo, Matthew J.   +2 more
core   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Health utility values associated with pharmaceutical treatment process attributes: a systematic review and meta-analysis. [PDF]

Health Qual Life Outcomes
Liu Y, Du X, Rong Z, Guo Z, Chang F, Lu Y, Dai Z, Lu Y.   +7 more
europepmc   +1 more source

On the Welfare Economic Foundations of Health Status Measures [PDF]

Measures of health status, such as e.g. the QALY (Quality Adjusted Life Years) measure, have been proposed as a tool in the economic assessment of new medical technologies, and its possible foundations in individual utility theory have been discussed in ...
Hans Keiding, Jens Leth Hougaard
core  

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Evaluation of health utility in trial-based cost-utility analyses for major cardiovascular disease: protocol for a systematic review. [PDF]

BMJ Open, 2023
Nakao Y, Kawakami H, Miyazaki S, Saito M, Luo Y, Yamamoto K, Yamaguchi O.   +6 more
europepmc   +1 more source